|
CNBC'S MOST SHARED
- Apartment Vacancy Rate Hits 22-Year High
- Investing in Tech Now
- What You'll See On My NASCAR Documentary Tonight
- Citigroup Replaces CFO, Shakes Up Top Management
- New Jobless Claims Plunge; Continuing Claims Hit Record
- Warren Buffett: Economy Needs Another Dose of Viagra
- Warren Buffett Tells CNBC Consumer Sales Remain "Very, Very Soft"
- Cramer?s Outrage
- July 10th in Market History
- Commercial Real Estate: 'Ticking Time Bomb'
- Chevron Says Q2 Hit by US Refining, Weak Dollar
- Stimulus Critics Put Obama, Democrats on Defensive
- Warren Buffett: Consumer Sales Remain 'Very, Very Soft'
- Don’t Get Burned By Hot Emerging Markets
- Busch: Chinese Bank Announces Bombshell
- Lenny Dykstra: 'Bank Fraud' Led to Bankruptcy
- Cramer: What to Expect This Earnings Season
- Christmas in July: Consumers to Out-Scrooge Scrooge
- Software Giants Rush to Cash In on Carbon-Trading
- Warren Buffett Tells CNBC Consumer Sales Remain "Very, Very Soft"
- July 10th in Market History
- Microsoft Plays a Game of Bing Pong
- Options Smell 'Blood' on Infosys
- Christmas in July: Consumers To Out-Scrooge Scrooge
- GM's Second Chance
- Art Cashin: Traders Weigh Obama Policy Changes
- Warren Buffett: Economy Needs Another Dose of Viagra
- Commercial Real Estate: 'Ticking Time Bomb'
CHICAGO, July 9 (Reuters) - Cardinal Health Inc warned customers it was "critically short" of a medical isotope used in nuclear imaging tests to check for heart disease or see if cancer has spread. In a July 7 letter to customers obtained by Reuters, the company's Nuclear Pharmacy Services unit in New York warned that on July 7-8 it would experience "the most significant shortage we have seen to date." Nick Tucker, a supervisor in the Bronx, New York unit confirmed the shortage, which stems from the May 17 shutdown of a nuclear reactor in Canada that produces a third of the world's medical isotope supply. (Reporting by Julie Steenhuysen; editing by Leslie Gevirtz) Keywords: CARDINAL/ISOTOPE (julie.steenhuysen@thomsonreuters.com ; +1 312 408 8131) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved.
The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.








